Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 3076 AL 3090

Lipid-based nanoparticles for drug delivery in Parkinson's disease

Cai H, Liu D, Xue WW, Ma L, Xie HT, Ning K.

Transl Neurosci. 2024 Dec 3;15(1):20220359. doi: 10.1515/tnsci-2022-0359. eCollection 2024 Jan 1.

Gut microbiota and Parkinson's disease: potential links and the role of fecal microbiota transplantation

Feng M, Zou Z, Shou P, Peng W, Liu M, Li X.

Front Aging Neurosci. 2024 Nov 29;16:1479343. doi: 10.3389/fnagi.2024.1479343. eCollection 2024.

Manipulated mesenchymal stem cell therapy in the treatment of Parkinson's disease

Ekrani ST, Mahmoudi M, Haghmorad D, Kheder RK, Hatami A, Esmaeili SA.

Stem Cell Res Ther. 2024 Dec 18;15(1):476. doi: 10.1186/s13287-024-04073-9.

Pre-clinical Aspects and Contemporary Treatments of Parkinson's Disease

Chhabra P, Rishabh, Singla S, Choudhary S, Kohli S, Bansal N, Bansal S.

CNS Neurol Disord Drug Targets. 2024;23(8):996-1014. doi: 10.2174/0118715273258646230920074421.

Serotonin Syndrome in Parkinson's Disease: Don't Get It Confused by a Tremor

Martins JD, Morais Passos R, Pardal N, Carvoeiro AC, Correia F.

Cureus. 2024 Nov 18;16(11):e73963. doi: 10.7759/cureus.73963. eCollection 2024 Nov.

Stem Cell Therapy for the Treatment of Parkinson's Disease: What Promise Does it Hold?

Nasrolahi A, Shabani Z, Sadigh-Eteghad S, Salehi-Pourmehr H, Mahmoudi J.

Curr Stem Cell Res Ther. 2024;19(2):185-199. doi: 10.2174/1574888X18666230222144116.

An update on new-age potential biomarkers for Parkinson's disease

Soni R, Mathur K, Shah J.

Ageing Res Rev. 2024 Feb;94:102208. doi: 10.1016/j.arr.2024.102208. Epub 2024 Jan 29.

Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson's Disease

Theis H, Pavese N, Rektorová I, van Eimeren T.

J Parkinsons Dis. 2024;14(s2):S353-S365. doi: 10.3233/JPD-230385.

PRKN-linked familial Parkinson's disease: cellular and molecular mechanisms of disease-linked variants

Clausen L, Okarmus J, Voutsinos V, Meyer M, Lindorff-Larsen K, Hartmann-Petersen R.

Cell Mol Life Sci. 2024 May 20;81(1):223. doi: 10.1007/s00018-024-05262-8.

A personal exploration of oral health in Parkinson's disease through the eyes of a multifaceted authority

Verhoeff MC, Raphael KG, Lobbezoo F.

J Oral Rehabil. 2024 Aug;51(8):1645-1652. doi: 10.1111/joor.13731. Epub 2024 May 20.

Bidirectional communication of the gut-brain axis: new findings in Parkinson's disease and inflammatory bowel disease

Wanyi Z, Jiao Y, Wen H, Bin X, Xuefei W, Lan J, Liuyin Z.

Front Neurol. 2024 May 24;15:1407241. doi: 10.3389/fneur.2024.1407241. eCollection 2024.

Research progress on the application of anti-gravity treadmill in the rehabilitation of Parkinson's disease patients: a mini review

Zheng Y, Shen Y, Feng R, Hu W, Huang P.

Front Neurol. 2024 May 31;15:1401256. doi: 10.3389/fneur.2024.1401256. eCollection 2024.

Telerehabilitation by Videoconferencing for Balance and Gait in People with Parkinson's Disease: A Scoping Review

Silva-Batista C, de Almeida FO, Wilhelm JL, Horak FB, Mancini M, King LA.

Geriatrics (Basel). 2024 May 23;9(3):66. doi: 10.3390/geriatrics9030066.

Distinguishing essential tremor from Parkinson's disease: clinical and experimental tools

Angelini L, Paparella G, Bologna M.

Expert Rev Neurother. 2024 Aug;24(8):799-814. doi: 10.1080/14737175.2024.2372339. Epub 2024 Jul 17.

Alpha Synuclein Toxicity and Non-Motor Parkinson's

Mazzotta GM, Conte C.

Cells. 2024 Jul 27;13(15):1265. doi: 10.3390/cells13151265.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias